INTRODUCTION
Tricuspid valve disease is a frequent accompaniment of mitral valve disease. Functional tricuspid regurgitation(TR) is caused by tricuspid valve (TV) annular dilation and altered right ventricular geometry secondary to left sided heart disease. 1 The concomitant correction of functional secondary tricuspid regurgitation (TR) remains underused despite recent data showing substantially poorer functional outcomes and survival if untreated. The traditional view that functional tricuspid regurgitation generally resolves with surgical correction of the primary lesions is no longer held. Significant TR secondary to right ventricular dilation and dysfunction associated with mitral valve disease is a risk factor for poor functional outcome and mortality after mitral valve surgery. 2 Surgical correction of significant functional TR at the time of left side valve surgery is recommended. repair in patients with secondary TR does not prolong bypass time in most cardiac operations and is also not a very complex procedure.
According to AHA/ACC guidelines 2017 update, intervention for TR is indicated in patients with severe TR, moderate TR with either tricuspid annular dilatation (greater than 4 cm) or Tricuspid index greater than 21 cm/m 2 .
There are several annuloplasty techniques available for the repair of tricuspid valve. The current study was under taken to assess the early impact of ring annuloplasty and De Vega annuloplasty techniques in functional significant TR in a predominantly rheumatic population. The recorded patient follows up was present till 6 months post-operatively (in the form of another TTE and clinical data sheet) at the time of data collection for this study. Eight patients (10%) were lost to in hospital mortality and eight patients (10%) were lost to follow-up. The follow up was 88.8% complete. No late deaths or cardiac reoperations occurred during follow up.
METHODS

Between
RESULTS
Mortality:
In hospital mortality was 10%. Mortality in ring annuloplasty group is 9% and De Vega group is 12%.
Freedom from residual significant TR (moderate or severe): Severe and moderate TR regressed in both groups. In immediate post-operative period 96% of patients in De Vega group and 91.65% in ring annuloplasty group had less than significant residual TR, but in early follow up period (at 6 months) 86.67% of patients in the ring annuloplasty group and 78.95% of patients in the De Vega group showed freedom from significant residual TR. There was no statistically significant difference in residual significant TR when ring annuloplasty was compared to De Vega repair (p=0.42 prior to discharge and p=0.44 at 6-month followup).
Event free survival which is defined as freedom from valve thrombosis, thromboembolism structural valve dysfunction, major bleeding events, endocarditis, TV reoperation during follow up, which was 100% in the present study, however the followup is too short to comment on this aspect. Improvement in NYHA status (NYHA I, NYHA II accepted as improvement): There was significant improvement in NYHA status (p=0.00001) after ring annuloplasty. There was also significant improvement in NYHA status (p=0.000074)
after De Vega repair. There was no prosthesis/valve related mortality in the follow-up period. Management options include conservative treatment, repair or replacement. Adequate physiologic and anatomic correction influences long term results of the repair. 10 From surgical point of view, several techniques are available to correct TR. De Vega annuloplasty is considered to be simple, easy, effective and least expensive of them, but recurrence and reoperation rate has been reported in 34% and 10% of survivors, at mid-term follow up. 11 De Vega annuloplasty has been criticized for being unpredictable and unreliable, perhaps due to the long suture line, which breaks or slides through the tissue as the annulus dilates. 12 Several studies have indeed found the simple suture annuloplasty to be a risk factor for tricuspid failure. 13, 14 This has not been so in the present study. A prospective randomized study of 159 patients conducted by Rivera et Bernal et al showed lesser re-operation rate after ring annuloplasty compared to De Vega repair. 17 Tang et al showed lower TR recurrence rates in patients receiving prosthetic ring annuloplasty with better long term and event free survival. 2 Carrier et al showed similar results between ring annuloplasty and De Vega. 18 In the present study, Patients with higher right ventricular systolic pressure in preoperative period showed residual significant TR in both the groups, but the larger annular index diameter showed no such association with residual significant TR in early postoperative period. Present results revealed no significant difference in the 2 techniques, Ring annuloplasty and De Vega Repair, with respect to residual significant TR, neither in immediate follow-up (p=0.42) nor at 6-month follow-up (p=0.44), similar to the results of Carrier etal. 18 In survivors, NYHA class improved in both the groups (Table 3)  (Table 4) . These results could be attributed to meticulous surgical techniques applied to both ring annuloplasty and De Vega repair and standardized post-operative management and follow-up.
CONCLUSION
The choice regarding which technique to address TV regurgitation can be a difficult one with literature available on various techniques. Present study shows similar results with both the techniques of TV repair, prosthetic ring annuloplasty and DeVega repair, when applied to functionally significant TR in a pre-dominantly rheumatic population. However, further studies with much larger sample size are required before an apt conclusion can be reached as to the efficacy of ring annuloplasty compared to DeVega repair.
